The tariff classification and country of origin marking of ampoules containing Apomorphine Hydrochloride as the active ingredient; ARTICLE 509
Reasoning
The tariff classification and country of origin marking of ampoules containing Apomorphine Hydrochloride as the active ingredient; ARTICLE 509
Cite this ruling
CBP Ruling I88116 (3004909140): The tariff classification and country of origin marking of ampoules containing Apomorphine Hydrochloride as the active ingredient; ARTICLE 509
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Agrisept, a veterinarymedicament, from Ireland.
The tariff classification of various products from Canada.
The tariff classification of opacifying preparations for X-ray examinations, and medicaments, consisting of mixed or unmixedproducts for therapeutic or prophylactic uses, put up in measureddoses or in forms or packings for retail sale, from Australia.
The tariff classification of Hetrazan (Diethylcarbamazinecitrate), a drug in bulk and dosage forms, and Caltrate Tablets,a high potency calcium supplement, from England and Australia
The tariff classification of Tila Muggawi Khas from Indiaand Pakistan